ABBV Stock Up 5% on Robust Q1 Performance: Time to Buy, Sell or Hold?Zacks Investment Research • 05/04/26
AbbVie: Balancing Potential Acquisition Impact With Positive Q1 2026 EarningsSeeking Alpha • 04/30/26
AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in QuebecGlobeNewsWire • 04/30/26
Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness MonthPRNewsWire • 04/30/26
AbbVie (ABBV) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 04/29/26
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia AreataPRNewsWire • 04/28/26
EvolveImmune Therapeutics Announces Achievement of Preclinical Milestone in Collaboration with AbbVieGlobeNewsWire • 04/28/26